Health Canada inspection
Lonza Biologics Inc.: Health Canada inspection of Jan 20, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | Lonza Biologics Inc. |
|---|---|
| City | Portsmouth |
| Province | NH |
| Country | United States |
| Program | GMP |
| Start date | Jan 11, 2022 |
| End date | Jan 20, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.